Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-06-20
1990-11-06
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536103, 514315, 514869, C08B 3716, A61K 31715, A61K 31445
Patent
active
049686739
ABSTRACT:
The use is described of [1R-[1.alpha.(Z),2.beta.,3.beta.,5.alpha.]]-(+)-7-[5-[[(1,1'-biphenyl)-4-y l]methoxy]-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic acid or a physiologically acceptable salt, solvate or cyclodextrin complex thereof in the manufacture of medicaments for the therapy or prophylaxis of chronic glomerular diseases including glomerulonephritis, lupus nephritis and systemic lupus erythematosus, renal failure, renal hypertension, hepatorenal syndrome, proteinurea (e.g. albuminurea and microalbuminurea), haemolytic uraemic syndrome and renal impairment following ureteral obstruction.
REFERENCES:
patent: 4834985 (1989-05-01), Elger et al.
Advances in Prostaglandins, Thromboxane and Leukotriene Research, vol. 13, (1985), pp. 131-139, (Patrono et al.).
Prostaglandins and The Kidney, (1983), pp. 399-406, (Foegh et al.).
The Lancet, 29 Aug. 1981, pp. 433 & 434, (Foegh et al.).
J. Clin. Invest., vol. 76, (1985), pp. 1011-1018, (Patrono et al.).
Clinical Research, vol. 35, (1987), pp. 544A (Ciabattoni et al.).
Am. J. Physiol., 233(5), (1977), pp. H573-H579, (Feigen et al.).
Prostaglandins and The Kidney, (1983), pp. 309-317, (Morrison et al.).
Am. J. Physiol., 248, (1985), pp. F753-F756, (Zipser).
Am. J. Med., vol. 80, (1986), pp. 34-45, (Stork et al.).
Prostaglandins and The Kidney, (1983), pp. 263-274, (Zipser et al.).
Am. J. Med., vol. 81, (1986), pp. 71-83, (Patrono et al.).
Glaxo Group Limited
Griffin Ronald W.
Webber Pamela S.
LandOfFree
Use of a thromboxane receptor antagonist in renal diseases and d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a thromboxane receptor antagonist in renal diseases and d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a thromboxane receptor antagonist in renal diseases and d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306957